$ALKS Balance Sheet | Understand Stock

$ALKS

$44.32 -$0.12 (0.27%) Close

$ALKS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
Restricted cash
Investments—short-term
Receivables, net
Inventory
Prepaid expenses and other current assets
Contract assets
Assets related to discontinued operations
Assets held for sale
Total current assets

PROPERTY, PLANT AND EQUIPMENT, NET
INVESTMENTS—LONG-TERM
RIGHT-OF-USE ASSETS
ASSETS RELATED TO DISCONTINUED OPERATIONS-LONG-TERM
ASSETS HELD FOR SALE-LONG-TERM
INTANGIBLE ASSETS, NET AND GOODWILL
INTANGIBLE ASSETS, NET
GOODWILL
Total iNTANGIBLE ASSETS, NET AND GOODWILL
DEFERRED TAX ASSETS
CONTINGENT CONSIDERATION
OTHER ASSETS
TOTAL ASSETS

LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable and accrued expenses
Accrued sales discounts, allowances and reserves
Operating lease liabilities—short-term
Contract liabilities—short-term
Current portion of long-term debt
Liabilities related to discontinued operations
Total current liabilities
OPERATING LEASE LIABILITIES—LONG-TERM
CONTRACT LIABILITIES—LONG-TERM
LIABILITIES RELATED TO DISCONTINUED OPERATIONS-LONG-TERM
CONTINGENT CONSIDERATION
LONG-TERM DEBT
DEFERRED TAX LIABILITIES
OTHER LONG-TERM LIABILITIES
Total liabilities
SHAREHOLDERS’ EQUITY:
Ordinary shares, par value, $0.01 per share; 450,000,000 shares authorized; 184,700,718 and 181,011,166 shares issued; and 167,541,198 and 165,607,028 shares outstanding at June 30, 2026 and December 31, 2025, respectively
Treasury shares, at cost (17,159,520 and 15,404,138 shares at June 30, 2026 and December 31, 2025, respectively)
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total shareholders’ equity
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

Comments